Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Chromatography B: Biomedical Sciences and Applications

• Publication date

  1999-03-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0378-4347(98)00566-0PMID 10219678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer

  2004cited by this paper
• Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.

  1998cited by this paper
• Preclinical pharmacokinetics of paclitaxel and docetaxel.

  1998cited by this paper
• Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

  1996cited by this paper
• Tissue distribution, metabolism and excretion of paclitaxel in mice

  1996cited by this paper
• Rapid screening of taxol metabolites in human microsomes by liquid chromatography/electrospray ionization-mass spectrometry.

  1996cited by this paper
• Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography.

  1996cited by this paper
• Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.

  1995cited by this paper
• Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

  1995cited by this paper
• Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching.

  1995cited by this paper
• Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography.

  1995cited by this paper
• Expedient Liquid Chromatographic Assay for Paclitaxel in Plasma After Its Administration to Cancer Patients

  1995cited by this paper
• Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography.

  1995cited by this paper
• High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine.

  1995cited by this paper
• Paclitaxel (Taxol)

  1994cited by this paper
• Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma.

  1994cited by this paper
• [Determination of new anticancer drug, paclitaxel, in biological fluids by high performance liquid chromatography].

  1994cited by this paper
• High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol) in human plasma.

  1993cited by this paper
• An enzyme immunoassay for the determination of taxol and taxanes in Taxus sp. tissues and human plasma.

  1993cited by this paper
• Analysis of taxol and related diterpenoids from cell cultures by liquid chromatography-electrospray mass spectrometry.

  1993cited by this paper
• Characterization of polyclonal and monoclonal anti-taxol antibodies and measurement of taxol in serum.

  1993cited by this paper
• Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.

  1993cited by this paper
• Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

  1991cited by this paper
• Analysis of anticancer drugs in biological fluids: determination of taxol with application to clinical pharmacokinetics.

  1990cited by this paper
• High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial.

  1987cited by this paper
• Phase I study of taxol administered as a short i.v. infusion daily for 5 days.

  1987cited by this paper
• Taxol stabilizes microtubules in mouse fibroblast cells.

  1980cited by this paper
• Promotion of microtubule assembly in vitro by taxol

  1979cited by this paper

• Sustainability in pharmaceutical analysis: greenness assessment of HPLC methods for paclitaxel

  2025cites this paper
• In-vitro/in-vivo evaluation of Paclitaxel Freeze-Dried micellar nanoparticles intended for buccal delivery

  2021cites this paper
• Therapeutic efficacy of a paclitaxel-loaded nanofibrillated bacterial cellulose (PTX/NFBC) formulation in a peritoneally disseminated gastric cancer xenograft model.

  2021cites this paper
• Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma

  2020cites this paper
• HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study.

  2020cites this paper
• Unusually favorable outcome of 6 consecutive patients with diffuse malignant peritoneal mesothelioma treated with repeated doses of intraperitoneal paclitaxel. A case series.

  2020cites this paper
• Acylated chitosan anchored paclitaxel loaded liposomes: Pharmacokinetic and biodistribution study in Ehrlich ascites tumor bearing mice.

  2019cites this paper
• QbD-Based Development of Cationic Self-nanoemulsifying Drug Delivery Systems of Paclitaxel with Improved Biopharmaceutical Attributes

  2019cites this paper
• Injectable diblock copolypeptide hydrogel provides platform to maintain high local concentrations of taxol and local tumor control

  2019cites this paper
• Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration

  2018cites this paper
• Antitumor effect of the paclitaxel-eluting membrane in a mouse model.

  2018cites this paper
• Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.

  2017cites this paper
• Development and qualification of an LC-MS/MS method for investigating the biological implications of micelle entrapped paclitaxel in cell culture and rats.

  2017cites this paper
• Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.

  2017cites this paper
• Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.

  2016cites this paper
• HPLC Method for the Dosage of Paclitaxel in Copaiba Oil: Development, Validation, Application to the Determination of the Solubility and Partition Coefficients

  2016cites this paper
• Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer.

  2016cites this paper
• A simple, rapid and sensitive RP-HPLC-UV method for the simultaneous determination of sorafenib & paclitaxel in plasma and pharmaceutical dosage forms: Application to pharmacokinetic study.

  2016cites this paper
• Lanreotide-conjugated PEG-DSPE micelles: an efficient nanocarrier targeting to somatostatin receptor positive tumors

  2015cites this paper
• The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-antibody conjugates containing encapsulated paclitaxel.

  2015cites this paper
• Pharmacokinetics and antitumor efficacy of paclitaxel-cyclodextrin complexes loaded in mucus-penetrating nanoparticles for oral administration.

  2014cites this paper
• Title Pharmacokinetics and antitumor efficacy of paclitaxel cyclodextrin complexes loaded in mucus penetrating nanoparticles for oral administration Author ( s ) names & affiliations

  2014cites this paper
• Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays.

  2014cites this paper
• Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.

  2014cites this paper
• A rapid and sensitive determination of paclitaxel in rat plasma by UPLC-MS/MS method: Application to a pharmacokinetic study

  2013cites this paper
• Polyarginine nanocapsules: a new platform for intracellular drug delivery

  2013cites this paper
• Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.

  2013cites this paper
• Poly-L-asparagine nanocapsules as anticancer drug delivery vehicles.

  2013cites this paper
• Ultra-sensitive assay for paclitaxel in intracellular compartments of A549 cells using liquid chromatography-tandem mass spectrometry.

  2013cites this paper
• In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.

  2013cites this paper
• LC-ESI-MS/MS determination of paclitaxel on dried blood spots.

  2012cites this paper
• Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.

  2012cites this paper
• Injectable in situ forming controlled release implant composed of a poly-ether-ester-carbonate and applications in the field of chemotherapy.

  2012cites this paper
• Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.

  2012cites this paper
• NUEVOS TRANSPORTADORES DE FARMACOS: NANOCÁPSULAS DE POLIASPARAGINA Y CASEÍNA

  2012cites this paper
• Drug-Loaded Lipid Nanoparticles for Improved Cancer Treatment: Engineering, In-Vitro, and In-Vivo Evaluation

  2012cites this paper
• Nanocápsulas policatiónicas: nuevos sistemas para la liberación intracelular de fármacos antitumorales

  2011cites this paper
• BPR0C261 is a novel orally active antitumor agent with antimitotic and anti‐angiogenic activities

  2011cites this paper
• Development and characterization of triazine based dendrimers for delivery of antitumor agent.

  2010cites this paper
• Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats

  2010cites this paper
• The Promotive Effects of Antioxidative Apigenin on the Bioavailability of Paclitaxel for Oral Delivery in Rats

  2010cites this paper
• Development and validation of a stability-indicating method for the quantitation of Paclitaxel in pharmaceutical dosage forms.

  2009cites this paper
• Chapter 7 Paclitaxel.

  2009cites this paper
• Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration.

  2009cites this paper
• Intraperitoneal administration of paclitaxel solubilized with poly(2‐methacryloxyethyl phosphorylcholine‐co n‐butyl methacrylate) for peritoneal dissemination of gastric cancer

  2009cites this paper
• Simultaneous Determination of Dexamethasone, Dexamethasone 21‐Acetate, and Paclitaxel in a Simulated Biological Matrix by RP‐HPLC: Assay Development and Validation

  2008cites this paper
• Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice.

  2008cites this paper
• Pharmacokinetics and Oral Bioavailability of Paclitaxel Microemulsion in Rats

  2008cites this paper
• Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.

  2008cites this paper
• Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: clinical and unexpected pharmacokinetic interactions.

  2008cites this paper
• Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle--a new strategy against peritoneal dissemination of gastric cancer.

  2008cites this paper
• Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.

  2007cites this paper
• Determination of paclitaxel in human and rat blood samples after administration of low dose paclitaxel by HPLC-UV detection.

  2007cites this paper
• Determination of paclitaxel in rat plasma by LC-MS-MS.

  2006cites this paper
• Liquid chromatography/tandem triple-quadrupole mass spectrometry for determination of paclitaxel in rat tissues.

  2006cites this paper
• Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.

  2006cites this paper
• A phase I study of flavopiridol and docetaxel

  2006cites this paper
• LC‐MS/MS for Determination of Paclitaxel in Rat Tissues: Application to a Biodistribution Study of Paclitaxel Nanoliposome Modified by PEO‐PPO‐PEO Triblock Copolymers

  2006cites this paper
• Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats.

  2006cites this paper
• Enhanced bioavailability of paclitaxel by bamboo concentrate administration

  2005cites this paper
• Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetics study.

  2005cites this paper
• The effect of verapamil on the pharmacokinetics of paclitaxel in rats.

  2005cites this paper
• Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.

  2005cites this paper
• Sensitive HPLC method for quantitation of paclitaxel (Genexol in biological samples with application to preclinical pharmacokinetics and biodistribution.

  2005cites this paper
• An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.

  2005cites this paper
• Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer.

  2004cites this paper
• Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres.

  2004cites this paper
• Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats.

  2004cites this paper
• Formulation Optimization of Paclitaxel Carried by PEGylated Emulsions Based on Artificial Neural Network

  2004cites this paper
• Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.

  2004cites this paper
• Rapid HPLC method for the determination of paclitaxel in pharmaceutical forms without separation.

  2004cites this paper
• Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions.

  2003cites this paper
• Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma.

  2003cites this paper
• Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography-mass spectrometry.

  2003cites this paper
• Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry.

  2003cites this paper
• Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions

  2003cites this paper
• Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay.

  2003cites this paper
• Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.

  2003cites this paper
• Injection Formulation of Paclitaxel Employing Solid Lipid Nanoparticles (SLN)

  2003cites this paper
• A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery.

  2003cites this paper
• Special problems associated with the bioanalysis of anti-cancer drugs

  2002cites this paper
• Cupressus lusitanica (Cupressaceae) leaf extract induces apoptosis in cancer cells.

  2002cites this paper
• Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model

  2002cites this paper
• Analytical approaches for traditional chinese medicines exhibiting antineoplastic activity.

  2001cites this paper
• Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers.

  2001cites this paper